Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Amyloidosis (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 2/Phase 3)
Anemia, Sickle Cell (Phase 1)
Angioplasty, Balloon, Coronary (Phase 2)
Anterior Wall Myocardial Infarction (Phase 2)
Atherosclerosis (Phase 2/Phase 3)
Autoimmune Diseases (Phase 2/Phase 3)
Brain Neoplasms (Phase 2/Phase 3)
Cardiomyopathies (Phase 1/Phase 2)
Cardiomyopathy, Dilated (Phase 2/Phase 3)
Cardiovascular Diseases (Phase 2)
Cerebral Palsy (Phase 2/Phase 3)
Chronic Limb-Threatening Ischemia (Phase 2)
Churg-Strauss Syndrome (Early Phase 1)
Craniocerebral Trauma (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Phase 2/Phase 3)
Ependymoma (Phase 2/Phase 3)
Fanconi Anemia (Phase 1)
Hearing Loss, Sensorineural (Phase 1/Phase 2)
Heart Diseases (Phase 2)
Heart Failure (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hepatitis, Chronic (Phase 2)
Hodgkin Disease (Phase 2)
Huntington Disease (Phase 1/Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Immunoglobulin Light Chains (Phase 2)
Infarction, Middle Cerebral Artery (Phase 2)
Intermittent Claudication (Phase 1)
Leg Ulcer (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Promyelocytic, Acute (Phase 4)
Liver Cirrhosis (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 3)
Lymphoma, Follicular (Phase 2/Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Medulloblastoma (Phase 2/Phase 3)
Mucositis (Phase 1)
Multiple Myeloma (Phase 4)
Multiple Sclerosis (Phase 1/Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 2)
Neoplasms (Phase 2/Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neuroblastoma (Phase 2)
Osteosarcoma (Phase 2)
Peripheral Arterial Disease (Phase 1)
Plasmacytoma (Phase 2)
Recurrence (Phase 1)
Scleroderma, Systemic (Phase 2/Phase 3)
Sclerosis (Phase 2/Phase 3)
Spinal Cord Injuries (Phase 2)
Stem Cells (Phase 1)
Stem Cell Transplantation (Phase 2)
Stroke (Phase 2)
Testicular Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue